{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:23Z","timestamp":1791214043502,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jbspin.2010.07.012","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T08:14:11Z","timestamp":1284884051000},"page":"94-97","source":"Crossref","is-referenced-by-count":14,"title":["Anti-PL7 antisynthetase syndrome under interferon therapy"],"prefix":"10.1016","volume":"78","author":[{"given":"Achille","family":"Aouba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-J\u00e9rome","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.07.012_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0010","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.23251","article-title":"Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion","volume":"112","author":"Hauschild","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders","volume":"207","author":"Stubgen","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2005.06.010","article-title":"Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b","volume":"37","author":"Venezia","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0035","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s10620-004-9602-3","article-title":"Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection","volume":"49","author":"Fuhrmann","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0040","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780390634","article-title":"Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection","volume":"39","author":"Ferri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0045","first-page":"605","article-title":"MHC Class I overexpression on muscles in early juvenile dermatomyositis","volume":"31","author":"Li","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0050","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","article-title":"Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction","volume":"52","author":"Nagaraju","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0055","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0060","first-page":"429","article-title":"Development of myositis after hepatitis C virus infection","volume":"23","author":"Mercado","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0070","unstructured":"Engel AG, Franzini-Armstrong C. Myology, basic and clinical. Editor, McGraw-Hill, 218, New-York 2004; pp. 1321\u201366."},{"key":"10.1016\/j.jbspin.2010.07.012_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2169\/internalmedicine.45.1772","article-title":"Antisynthetase syndrome associated with sarcoidosis","volume":"45","author":"Asanuma","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2010.07.012_bib0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","article-title":"Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology","volume":"35","author":"Dimitri","year":"2007","journal-title":"Muscle Nerve"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10002034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10002034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T00:51:25Z","timestamp":1544230285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1297319X10002034"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.07.012","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}